Rebif ® (interferon beta-1a) is a prescription medicine used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It is not known if Rebif is safe and effective in children.

This guide contains information on how to use Rebif® Rebidose®, a pre-assembled, single-use autoinjector that administers one dose of Rebif® (interferon beta-1a) for the treatment of relapsing forms of multiple sclerosis.

REBIF is a prescription medicine used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It is a form of protein called beta interferon that is produced in the body. It is not known if REBIF is safe and effective in children.

REBIF (interferon beta-1a) is indicated for the treatment of patients with relapsing forms of multiple sclerosis to decrease the frequency of clinical exacerbations and delay the accumulation of...

2013年1月3日 · EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Rebif® Rebidose® (interferon beta-1a), a single-use auto-injector for the self-administration of Rebif, a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS).

Pr REBIF ® (Interferon beta-1a) ... EMD Serono is the healthcare business of Merck KGaA, Darmstadt, Germany in Canada and the United States. CA-MAV-00264 ...

2025年1月2日 · Interferon beta-1a is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Brand names include Rebif, Rebif Redidose, and Avonex.

REBIF (interferon beta-1a), for subcutaneous injection ... REBIF is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease ...

Rebif is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. IMPORTANT SAFETY INFORMATION.

2023年8月4日 · REBIF is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. The recommended dose of REBIF is either 22 mcg or 44 mcg injected subcutaneously three times per week.